Justin Timberlake has revealed he’s been diagnosed with Lyme disease, a tick-borne illness that can cause severe fatigue, nerve pain, and flu-like symptoms if left untreated. The announcement follows criticism of his recent performance at the Electric Castle festival in Romania.
The singer shared the news on Instagram, stating he wanted to shed light on what he’s “been up against behind the scenes” throughout his global Forget Tomorrow Tour, which concluded July 30 in Turkey.
“If you’ve experienced this disease or know someone who has — then you’re aware: living with this can be relentlessly debilitating, both mentally and physically,” Timberlake said.
What is Lyme disease?
Lyme disease is caused by the Borrelia burgdorferi bacteria, transmitted through the bite of infected blacklegged ticks. The Centers for Disease Control and Prevention (CDC) lists early symptoms as:
- Fever and chills
- Headache
- Fatigue
- Muscle and joint aches
- Swollen lymph nodes
- A distinctive rash known as erythema migrans
If untreated, the infection can spread to the nervous system, heart, and joints, leading to long-term health complications.
Timberlake’s symptoms explained
In his statement, Timberlake said he suffered from symptoms like:
- “A massive amount of nerve pain”
- Persistent fatigue
- Flu-like sickness mid-performance
Despite the challenges, Timberlake decided not to cancel the tour, stating that “the joy that performing brings me far outweighs the fleeting stress my body was feeling.”
Early detection remains a challenge
Early Lyme disease detection is notoriously difficult. While the telltale rash is often a clue, not every patient develops one. According to Dr. Paul Auwaerter of Johns Hopkins University, current antibody-based blood tests may not detect Lyme during the first few weeks after infection.
A new AI-powered test, LymeSeek, developed by ACES Diagnostics in partnership with Tulane and Arizona State universities, aims to improve early-stage detection by using machine learning to identify a broader set of antibodies.
Why early testing matters
“Having a test that’s accurate early is so important… hopefully that will prevent long term complications down the line,” said Holly Ahern, ACES’ chief scientific officer.
ACES submitted its clinical plan to the FDA in July, with trials expected to begin January 2026.
Celebrity transparency may reduce stigma
Timberlake acknowledged feeling reluctant to share his condition, citing how he was raised “to keep something like this to yourself.” But after public speculation and criticism, he opted for transparency.
The response from fans and fellow artists was overwhelmingly supportive. Musician Miguel commented, “Rooting for your healing familia, massive of you to forge ahead… for the love of the music and your audience.”
What happens next?
Timberlake has not indicated whether future appearances will be affected by his diagnosis. Meanwhile, his disclosure shines a spotlight on the often-overlooked struggles of those living with Lyme disease and the ongoing need for better testing and awareness.
This content is brought to you by the FingerLakes1.com Team. Support our mission by visiting www.patreon.com/fl1 or learn how you send us your local content here.